Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Moderna, Inc. between January 18, 2023 and ...

In the 20th century, it was the advent of antibiotics. More recently, it was the synthesis of vaccines using messenger RNA ...

MicroRNAs (miRNAs) are small RNA molecules, approximately 20 to 25 nucleotides in length. They play an important role in regulating gene expression by determining how much protein will be synthesized ...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Moderna, Inc. (NASDAQ:MRNA) have reached a stipulation in their ongoing ...

Avidity Biosciences excels in antibody oligonucleotide conjugates with its stock tripling in the past year due to innovative ...

Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of ...

The genome inside each of our cells is modeled by tension and torsion—due in part to the activity of proteins that compact, ...

We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, ...

Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

Researchers have developed a promising CAR-T cell therapy targeting glioblastoma, the most aggressive brain tumor.

As you read this, a white box the size of a refrigerator is hurtling through space at 17,500 miles per hour (28,000 kph), ...